ZA992793B - Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction. - Google Patents

Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction.

Info

Publication number
ZA992793B
ZA992793B ZA9902793A ZA992793A ZA992793B ZA 992793 B ZA992793 B ZA 992793B ZA 9902793 A ZA9902793 A ZA 9902793A ZA 992793 A ZA992793 A ZA 992793A ZA 992793 B ZA992793 B ZA 992793B
Authority
ZA
South Africa
Prior art keywords
treatment
sexual dysfunction
pde5 inhibitors
cgmp pde5
pyrazolopyrimidinone cgmp
Prior art date
Application number
ZA9902793A
Inventor
Mark Edward Bunnage
John Paul Mathias
Stephen Derek Albert Street
Anthony Wood
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA992793B publication Critical patent/ZA992793B/en

Links

ZA9902793A 1998-04-20 1999-04-19 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction. ZA992793B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808315.7A GB9808315D0 (en) 1998-04-20 1998-04-20 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA992793B true ZA992793B (en) 2000-10-19

Family

ID=10830602

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9902793A ZA992793B (en) 1998-04-20 1999-04-19 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction.

Country Status (3)

Country Link
GB (1) GB9808315D0 (en)
HN (1) HN1999000041A (en)
ZA (1) ZA992793B (en)

Also Published As

Publication number Publication date
HN1999000041A (en) 2001-06-18
GB9808315D0 (en) 1998-06-17

Similar Documents

Publication Publication Date Title
IL138907A0 (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
GC0000096A (en) Treatment of female sexual dysfunction.
EP1027054A4 (en) Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
IL151646A0 (en) Use of pyrido[3,2-e]-pyrazinones as inhibitors of phosphodicesterase 5 for treating erectile dysfunction
ZA200108012B (en) Method of enhancing the efficacy of anti-tumor agents.
HUP0200912A3 (en) Compositions comprising phosphodiesterase inhibitors for the treatment of sexual disfunction
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
AU2003219981A1 (en) Benzimidazole-derivatives for the treatment of sexual dysfunction
AU4068599A (en) Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
AU3776799A (en) Methods for treating female sexual dysfunction
GB0130219D0 (en) Compounds for the treatment of sexual dysfunction
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
MXPA03004017A (en) Method for the treatment of inflammation.
PL362980A1 (en) Treatment of sexual dysfunction
AU8906201A (en) Methods and compositions for the treatment and prevention of sexual dysfunction
ZA200203069B (en) Peptides for treatment of erectile dysfunction.
AU2000275972A1 (en) Pde iii inhibitors for treating sexual dysfunction
ZA992793B (en) Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction.
AU2001237379A1 (en) Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction
SI1047428T1 (en) Use of morpholinol for the treatment of sexual dysfunction
ZA200006374B (en) Compound for the treatment of female sexual dysfunction.
HUP0500698A2 (en) Use of an ascomycin for the treatment of blepharitis